GB201915598D0 - Methods for determining the invasive and/or metastic potential of a tumour - Google Patents
Methods for determining the invasive and/or metastic potential of a tumourInfo
- Publication number
- GB201915598D0 GB201915598D0 GB201915598A GB201915598A GB201915598D0 GB 201915598 D0 GB201915598 D0 GB 201915598D0 GB 201915598 A GB201915598 A GB 201915598A GB 201915598 A GB201915598 A GB 201915598A GB 201915598 D0 GB201915598 D0 GB 201915598D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- tumour
- invasive
- determining
- methods
- metastic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5748—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
- G01N2333/96491—Metalloendopeptidases (3.4.24) with definite EC number
- G01N2333/96494—Matrix metalloproteases, e. g. 3.4.24.7
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201915598A GB201915598D0 (en) | 2019-10-28 | 2019-10-28 | Methods for determining the invasive and/or metastic potential of a tumour |
CN202080076313.9A CN114641582A (en) | 2019-10-28 | 2020-10-27 | Method for determining the invasiveness and/or the metastatic potential of a tumor |
PCT/GB2020/052718 WO2021084242A1 (en) | 2019-10-28 | 2020-10-27 | Methods for determining the invasive and/or metastatic potential of a tumour |
EP20800285.7A EP4052039A1 (en) | 2019-10-28 | 2020-10-27 | Methods for determining the invasive and/or metastatic potential of a tumour |
US17/755,279 US20220404365A1 (en) | 2019-10-28 | 2020-10-27 | Methods for determining the invasive and/or metastatic potential of a tumour |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201915598A GB201915598D0 (en) | 2019-10-28 | 2019-10-28 | Methods for determining the invasive and/or metastic potential of a tumour |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201915598D0 true GB201915598D0 (en) | 2019-12-11 |
Family
ID=68768868
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB201915598A Ceased GB201915598D0 (en) | 2019-10-28 | 2019-10-28 | Methods for determining the invasive and/or metastic potential of a tumour |
Country Status (5)
Country | Link |
---|---|
US (1) | US20220404365A1 (en) |
EP (1) | EP4052039A1 (en) |
CN (1) | CN114641582A (en) |
GB (1) | GB201915598D0 (en) |
WO (1) | WO2021084242A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113502328A (en) * | 2021-05-27 | 2021-10-15 | 深圳市人民医院 | Application of reagent for detecting expression level of marker in sample in preparation of kit for detecting or diagnosing breast cancer |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999021583A1 (en) * | 1997-10-29 | 1999-05-06 | Warner-Lambert Company | Method of inhibiting metastases of cancer cells |
US8609332B2 (en) * | 2006-09-20 | 2013-12-17 | Queen's University Of Belfast | Assay |
US11913957B2 (en) * | 2011-12-21 | 2024-02-27 | Biodesix, Inc. | Compositions, methods and kits for diagnosis of lung cancer |
GB2554703A (en) * | 2016-10-05 | 2018-04-11 | Univ Bradford | Compound for use in medicine |
WO2018065771A1 (en) * | 2016-10-05 | 2018-04-12 | University Of Bradford | Inhibitor of ran at transcriptional level for use in the treatment of cancer |
-
2019
- 2019-10-28 GB GB201915598A patent/GB201915598D0/en not_active Ceased
-
2020
- 2020-10-27 CN CN202080076313.9A patent/CN114641582A/en active Pending
- 2020-10-27 US US17/755,279 patent/US20220404365A1/en active Pending
- 2020-10-27 EP EP20800285.7A patent/EP4052039A1/en active Pending
- 2020-10-27 WO PCT/GB2020/052718 patent/WO2021084242A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20220404365A1 (en) | 2022-12-22 |
CN114641582A (en) | 2022-06-17 |
EP4052039A1 (en) | 2022-09-07 |
WO2021084242A1 (en) | 2021-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL268815A (en) | Compositions and methods for tumor transduction | |
IL269124A (en) | Nrf and hif activators/hdac inhibitors and therapeutic methods using the same | |
EP3292511A4 (en) | Computer-assisted tumor response assessment and evaluation of the vascular tumor burden | |
IL269718A (en) | Combination of an anti-pd-l1 antibody and a dna-pk inhibitor for the treatment of cancer | |
IL273782A (en) | Bacterial and cell compositions for the treatment of colorectal cancer and methods for assessing a prognosis for patients having the same | |
SG11202001432WA (en) | Improving the taste of consumables | |
EP3863615A4 (en) | Methods for the treatment of solid tumor cancers using illudins and biomarkers | |
IL270717A (en) | Biomarkers for diagnosis of lung cancer | |
GB2569154B (en) | Methods and systems for determining the shape of a radiotherapy beam | |
IL272810A (en) | Methods of diagnosing and treating lung cancer | |
EP4357777A3 (en) | Method for predicting cancer progression by nanomechanical profiling | |
GB201814350D0 (en) | Diagnosis of cancer | |
GB201915598D0 (en) | Methods for determining the invasive and/or metastic potential of a tumour | |
EP3607066A4 (en) | Methods of detecting lung cancer | |
EP3607320A4 (en) | Compositions and methods of diagnosing pancreatic cancer | |
GB201619808D0 (en) | Biomarkers for the prognosis and diagnosis of cancer | |
GB201911216D0 (en) | Methods of determining the margin of a tumour | |
GB201906201D0 (en) | Method for the detection of protate cancer | |
GB201905861D0 (en) | Methods of detecting cancer | |
EP3716973A4 (en) | Methods of inhibiting tumor metastasis | |
SI3794148T1 (en) | Methods for the diagnosis of aneurysm or cancer | |
EP3630287A4 (en) | Radiolabeled and fluorescent parp inhibitors for imaging and radiotherapy | |
GB201719995D0 (en) | Drum lid and method of making the same | |
SG11202113075WA (en) | Methods for determining the likelihood of lung cancer | |
ZA202107946B (en) | Methods for the diagnosis of lung cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |